ABBE Laboratories, Inc., 1095 Route 110, Suite E, F Farmingdale , NY 11735-4815 United StatesFEI 3004433842Issued Aug 6, 2025Center for Drug Evaluation and Research (CDER)
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3004433842.
Violations4
Issue DateAug 6, 2025
Product TypeDrugs
StatusOpen
Letter Details
Firm
ABBE Laboratories, Inc.
Location
ABBE Laboratories, Inc., 1095 Route 110, Suite E, F Farmingdale , NY 11735-4815 United States
FEI Number
3004433842
Country
United States
Issue Date
August 06, 2025
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
Open
Subject
CGMP/Finished Pharmaceuticals/Adulterated
ABBE Laboratories, Inc. FDA Warning Letter, August 6, 2025
Talk to a Specialist